[1]
“Bevacizumab in Neoadjuvant Treatment of Patients with Liver Metastases from Colorectal Carcinoma”, TAJ: J of Teachers Assoc, vol. 24, no. 2, pp. 101–105, Nov. 2018, doi: 10.3329/taj.v24i2.37512.